medigraphic.com

2001, Number 2

<< Back Next >>

Arch Cardiol Mex 2001; 71 (2)

Rheumatic fever

Soto LME, González CFC, Estrada L, Guel LL, Abud MC, Reyes PA

Language: Spanish
References: 53
Page: 127-135
PDF size: 187.66 Kb.


ABSTRACT

Objective: To assess the incidence of acute Rheumatic Fever (ARF). Patients and methods: A retrospective, descriptive, observational study on the first attack and recurrence was performed in a general hospital and a reference center. Results: By Jones criteria: 67 cases, 39 women and 28 men; 58% first attack, 42% recurrence. Higher incidence during spring-winter. The most common major criteria were: carditis, polyarthritis. The most common minor criteria were: fever, arthralgias and acute phase reaction markers. No differences between hospitals were noted. Evidence of contact with streptococcus was found. Mitral, aortic and tricuspid valves were commonly affected. Incidence in the age group › 5 ‹ 20 was 7/1000. Discussion: Incidence of ARF has decreased, but has not been eradicated. It occurs in developing countries, where it remains an issue of public health. Failures in clinical suspicion, prophylaxis, and adherence to treatment influence this situation. Education for health, early diagnosis, and primary and secondary prophylaxis should be reinforced.


REFERENCES

  1. León AP, Cano C, Argott EE: Aspectos bacteriológicos y serológicos de faringitis estreptocóccica en la ciudad de México. Bol Of Sanit Panam 1985; 99: 53-60.

  2. Kaplan EL: Medical Progress. The group A streptococcal upper respiratory tract carrier state: An enigma. J Pediat 1980; 97: 337-45.

  3. Breese BB, Disney FA: Factors influencing the spread of beta hemolytic streptococcal infections within the family group. Pediatrics 1956; 17: 83-7.

  4. Kaplan E, Gastanaduy A, Huwe B: The role of the carrier treatment failures after antibiotic therapy for group streptococci in the upper respiratory tract. J Lab Clin Med 1981; 98: 326-29.

  5. Cavelti PA: Autoantibodies in rheumatic fever. Proc Soc Exp Biol Med 1945; 60: 379-81.

  6. Kaplan MH, Frengley JD: Autoinmunity to the Heart in Cardiac disease. Current concepts of the relation of autoimmunity to rheumatic fever, postcardiotomy and postinfarction syndromes and cardiomyopathies. Am J Cardiol 1969; 24: 459-73.

  7. Kaplan MH: Immunologic relation of streptococcal and tisue antigens. Properties of an antigen in certain strains of group A streptococci exhibiting an immunologic cross-reaction with human heart tissue. J Immunol 1963; 90: 595-606.

  8. Patarroyo ME, Winchester RJ, Vejerano A, Gibofsky A, Chalem F, Zabriskie JB, et al: Association of a B-cell alloantigen with suceptibility to rheumatic fever. Nature 1979; 278: 173-4.

  9. Zabriskie JB, Lavenchy D, Williams RC, Fu SM, Yeadon CA, Fotino M, et al: Rheumatic fever-associated B cell alloantigens as identified by monoclonal antibodies. Arth & Rheum 1985; 28: 1047-51.

  10. Kaplan E, Markowitz M: The fall and rise of rheumatic fever in the United States: a commentary. Int J Cardiol 1988; 21: 3-10.

  11. Gus S, Zaslavsky C, Seger JM, Strehl R: Epidemiologia da febre reumática. Estudo local. Arg Bras Cardiol 1995; 65: 325-6.

  12. Veasy LG, Wiedmeier SE, Orsmond GS, Ruttenberg HD, Boucek M, Roth SJ, et al: Resurgence of acute rheumatic fever in the intermountain of the United States. N Engl J Med 1987; 316 (8): 421-427.

  13. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schilievert PM, et al: Severe group A streptococcal infections associated with a toxic shock-like syndrome an scarlet fever toxin A. N Engl J Med 1989; 321: 1-7.

  14. Padmayati S: Rheumatic fever and rheumatic heart disease in developing countries. Bull WHO 1978; 56: 543-50.

  15. Carapetis JR, Currie BJ: Rheumatic chorea in Northern Australia: a clinical and epidemiological study. Arch Dis Child 1999; 80: 353-8.

  16. Hosier DM, Craenen JM, Teske DW, Wheller J: Resurgence of acute Rheumatic. Am J Dis Child l987; 141: 730-3.

  17. Jones TD: The diagnosis of rheumatic fever. J Am Med Ass 1944; 126: 481-4.

  18. Special Writing Group of the Commitee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association: Guidelines for the diagnosis of rheumatic fever. JAMA 1992; 268: 2069-73.

  19. Dajani AS, Ayoub E, Bierman FZ, Bisno AL, Denny FW, Durack DT, et al: Guidelines for the diagnosis of Rheumatic fever Jones Criteria, Updated 1992. Circulation 1993; 87: 302-7.

  20. Martínez-Lavín M, Amigo MC: The value of the Jones criteria in the recognition of acute rheumatic fever: fifty years later. Clin Exp Rheumatol 1994; 12: 355-6.

  21. Chavez I: Incidencia de Cardiopatías en México. Arch Lat Amer Cardiol Hematol 1942; 12: 87-9.

  22. Chavez I, Robles Gil J, Ponce de León J, Chávez Rivera I: Algunos aspectos de la epidemiología de la fiebre reumática en la ciudad de México. Primer Simposium Internacional sobre Fiebre Reumática. Instituto Nacional de Cardiología/SIBIC. México DF, 1958; 43.

  23. Kuri J, Fernández de la Vega P, Mata LA, Attie F, Zamora C: Estudio del primer brote de fiebre reumática. Observación y evolución clínica de 40 pacientes a largo plazo. Arch Inst Cardiol Méx 1977; 47: 19-36.

  24. Amezcua-Valadez FJ, Aranda-Orozco S, García-Procel E, Monroy-Alvarado G: En Aspectos Epidemiológicos. Capítulo II. Fiebre Reumática. Editorial Amezcua-Valadez FJ, Aranda-Orozco S. Primera edición, México D.F, IMSS 1985; 35.

  25. Stollerman GH: The Global Impact of Penicillin. Then and Now. Mt Sinai Med 1993; 60: 112-19.

  26. Stahlman MT, Tenn Nashville, Denny FW: The Prophylaxis of Streptococcal Infections in Patients with Rheumatic Fever. A comparison Between sulfadiazine and Erythromycin. J Dis Med Child 1959; 98: 80-85.

  27. Kuri J, Fernández de la Vega P, Attie F, Olvera E, Olvera S, Mispireta E: Profilaxis secundaria en 564 pacientes con cardiopatía reumática. Arch Inst Cardiol Méx 1978; 48: 1-19.

  28. Di Sciascio G, Taranta A: Rheumatic fever in children. Am Heart J 1980; 99 (5): 635-58.

  29. Amigo MC, Martínez Lavín M, Reyes PA: Acute Rheumatic Fever. Rheum Dis Clinic 1993; 19: 333-50.

  30. Froude JRL, Gibofsky A, Zabriskie JB: Rheumatic fever. Curr Op Rheum 1989; 1: 205-208.

  31. Kaplan E: Rheumatic Fever. Curr Op Rheum 1990; 2: 836-838.

  32. Salinas L, Fernández de la Reguera G, Gutiérrez López M: Heterogeneidad etiopatogénica de las valvulopatías mitral y aórtica. Estudio clínico patológico. Arch Inst Cardiol Méx 1978; 48: 48-61.

  33. Bland EF: Chorea as a manifestation of rheumatic fever, a long term perspective. Trans Am Clin Climatol Assoc 1961; 73: 209-16.

  34. Stollerman GH: Streptococcal Vaccines and global Strategies for Prevention of Rheumatic Fever. Am J Med 1980; 68: 636-38.

  35. Centers for disease Control: Acute rheumatic fever at a Navy training center-San Diego, California. MMWR 1988; 37: 101-4.

  36. Centers for disease Control: Acute rheumatic fever among Army trainees-Fort Leonard Wood, Missouri 1987-1988. MMWR 1988; 37: 519-22.

  37. Annegers JF, Pillman NL, Wiedman WH, Kurland LT: Rheumatic fever in Rochester, Minnesota, 1935-1978. Mayo Clin Proc 1982; 57: 753-7.

  38. Wald ER, Dashefsky B, Feidt C, Chiponis D, Byers C: Acute rheumatic fever in western Pennsylvania and the tri-state area. Pediatrics 1987; 80: 371-4.

  39. Zabriskie JB: Rheumatic fever: The interplay between host, genetics, and microbe. Lewis A. Conner Memorial lecture. Circulation 1985; 71: 1077-1086.

  40. Williams RC Jr: Molecular Mimicry and Rheumatic Fever. Clin Rheum Dis 1985; 11: 573-89.

  41. Tomai M, Kotb M, Majumdar G: Superantigenicity of streptococcal M protein. J Exp Med 1990; 172: 359-62.

  42. Gulizia JM, Cunningghann MW, McManus B: Immunoreactivity of anti-streptococcal monoclonal antibodies to human heart valves. Am J Pathol 1991; 138: 285-301.

  43. Odio A: The incidence of acute rheumatic fever in a suburban area of los Angeles. A ten-year study. West J Med 1986; 144: 179-8.

  44. Gordis L: The virtual disappearance of rheumatic fever in the United States. Lessons in the rise and fall of disease. J Am Med Ass 1985; 72: 1155-62.

  45. Neutze JM, Clarkson PM: Rheumatic fever. An unsolved problem in New Zeland. NZ Med J 1984; 97: 591-3.

  46. Vijaykumar M, Narula J, Reddy KS, Kaplan EL: Incidence of rheumatic fever and prevalence of rheumatic heart disease in India. Int J Cardiol 1994; 43: 221-8.

  47. Carapetis JR, Currie BJ: Mortality due to acute rheumatic fever and rheumatic heart disease in the Northern Territory: a preventable cause of death in aboriginal people. Aust NZ J Public Healt 1999; 23: 159-63.

  48. Carapetis JR, Wolff DR, Currie B: Acute rheumatic fever and rheumatic heart disease in the top end of Australia Northern Territory. Med J Aust 1996; 164: 146-9.

  49. Augestad KM, Martyshova K, Martyshov S, Foederov B, Lie M: Rheumatic fever and rheumatic heart disease in Northwest Russia. Tidsskr Nor Laegeforen 1999; 119: 1456-9.

  50. Olgunturk R, Aydin GB, Tunaoglu FS, Akalin N: Rheumatic heart disease prevalence among, schoolchildren in Ankara Turkey. Turk J Pediatr 1999; 41: 201-6.

  51. Wannamaker LW, Rammelkamp CH, Denny FW, Brink WP, Houser HS, Hahn E, et al: Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am J Med 1951; 10: 573-82.

  52. Stahlman MT, Tenn N, Denny FW: The Prophylaxis of streptococcal infections in patients with Rheumatic fever. Am J Dis Child 1959; 98: 80-5.

  53. Thatai, Turi ZG: Current guidelines for the treatment of patients with rheumatic fever. Drugs 1999; 57 (4): 545-55.




2020     |     www.medigraphic.com